The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression

Current Psychiatry Reports

Volumn 8, Issue 6, 2006, Pages 452-457

  Vergne, Derick E ^b   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; MILNACIPRAN; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CENTRAL NERVOUS SYSTEM; DISEASE MODEL; DRUG EFFICACY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PROMOTER REGION; REVIEW; RISK FACTOR; SEROTONINERGIC NERVE CELL; STRESS;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER, MAJOR; GENOTYPE; HUMANS; LIFE CHANGE EVENTS; MICE; POLYMORPHISM, GENETIC; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 33845914341     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-006-0050-y     Document Type: Review

References (43)

1. Rapport MM, Green AA, Page IH: Crystalline serotonin. Science 1948, 108:329-330.
2. Lucki I: The spectrums of behaviors influenced by serotonin. Biol Psychiatry 1998, 44:151-162.
3. Ressler KJ, Nemeroff CB. The role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000, 12:2-19.
4. Nemeroff CB, Knight DL, Krishnan RR, et al.: Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. Arch Gen Psychiatry 1988, 45:919-923.
5. Parsey RV, Hastings RS, Oquendo MA, et al.: Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 2006, 163:.52-58.
6. Hariri AR, Holmes A: Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogni Sci 2006, 10:182-191.
7. Malison RT, Price LH, Berman R, et al.: Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 1998, 44:1090-1098.
8. Arango V, Underwood MD, Boldrini M, et al.: Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001, 25:892-903.
9. Bradley CC. Blakely RD: Alternative splicing of the human serotonin transporter gene. J Neurochem 1997, 69:1356-1367.
10. Heils A, Lesch KP: Allelic variation of human serotonin transporter gene expression. J Neurochem 1996, 66:2621-2624.
11. Staley JK, Malison RT, Innis RB: Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression. Biol Psychiatry 1998, 44:534-549.
12. Heinz A, Jones DW, Mazzanti C, et al.: A relationship between serotonin transporter genotype, an in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000, 47:643-649.
13. Gonda X, Rihmer Z, Zsombok T, et al.: The 5HTTLPR polymorphism of the serotonin transporter gene is associated with affective temperaments as measured by TEMPS-A. J Affect Disord 2006, 91:125-131.
14. Roiser JP, Blackwell AD, Cools R, et al.: Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion. Neuropsychopharmacology 2006, In press.
15. Hariri A, Drabant E, Munoz K, et al.: A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 2005, 62:146-152.
16. Ramasubbu R, Tobias R, Buchan A, et al.: Serotonin transporter gene promoter region polymorphism associated with poststroke depression. J Neuropsychiatry Clin Neurosci 2006, 18:96-99.
17. Joiner T, Johnson F, Soderstrom K, et al.: Is there an association between serotonin transporter gene polymorphism and family history of depression? J Affect Disord 2003, 77:273-275.
18. Arias B, Rosa C, Gasto C, et al.: 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-week follow up study. J Clin Psychopharmacol 2003, 23:563-567.
19. Hong NG, Easteal S, Tan S, et al.: Serotonin transporter polymorphism and clinical response to sertraline across ethnicities. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:953-957.
20. Serretti A, Benedetti F, Zanardi R, et al.: The influence of serotonin transporter promoter polymorphism (SERTPR) and other polymorphism of the serotonin pathway on the efficacy of antidepressant treatments. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1074-1084.
21. Rausch J: Initial conditions of psychotropic drug response: studies of serotonin transporter long promoter region (5-HTTLPR), serotonin transporter efficiency, cytokine and kinase gene expression relevant to depression and antidepressant outcome. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1046-1061.
22. Kim DK, Lim SW, Lee S, et al.: Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 2000, 11:215-219.
23. Yoshida K, Ito K, Sato K, et al.: Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:383-386.
24. Yoshida K, Takahashi H, Higuchi H, et al.: Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am J Psychiatry 2004, 161:1575-1580.
25. Sanchez MM, Noble PM, Lyon CK, et al.: Alterations in diurnal cortisol rhythm and acoustic startle response in non-human primates with adverse rearing. Biol Psychiatry 2005, 57:373-381.
26. Gutman DA, Nemeroff CB: Neurobiology of early life stress: rodent studies. Semin Clin Neuropsychiatry 2002, 7:89-95.
27. Bennett AJ, Lesch KP, Heils A, et al.: Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry 2002, 7:118-122.
28. Heim C, Nemeroff CB: The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 2001, 49:1023-1039.
29. Barr CS, Newman T, Shannon C, et al.: Rearing conditions and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques. Biol Psychiatry 2004, 55:733-738.
30. Kendler KS, Kuhn J, Prescott C: The interrelationship of neuroticism, sex and stressful life events in the prediction of episodes of major depression. Am J Psychiatry 2004, 161:631-636.
31. Caspi A, Sugden K, Moffit T, et al.: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
32. Wilhem K, Mitchell P, Niven H, et al.: Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry 2006, 188:210-215.
33. Kendler K, Kuhn J, Vittum J, et al.: The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression. Arch Gen Psychiatry 2005, 62:529-535.
34. Nobile M, Giulia M, Giordia R, et al.: A case control and family-based association study of the 5-HTTLPR in pediatric-onset depressive disorders. Biol Psychiatry 2004, 56:292-295.
35. Kaufman J, Yang BZ, Douglas-Palumberi H, et a1.: Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A 2004, 101:17316-17321.
36. Kaufman J, Yang BZ, Douglas-Palumberi H, et al.: Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006, 59:673-680.
37. Davis M: The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. Trends Pharmacol Sci 1992, 13:35-41.
38. Pezawas L, Meyer-Lindberg A, Drabant E, et al.: 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005, 8:828-834.
39. Heinz A, Braus D, Smolka M, et al.: Amygdala prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005, 8:20-21.
40. Kaufman J, Plotsky P, Nemeroff CB, et al.: Effects of early adverse experiences on brain structure and function: clinical implications. Biol Psychiatry 2000, 48:778-790.
41. Maines LW, Keck J, Smith J, et al.: Corticosterone regulation of serotonin transporter and 5-HT1A receptor expression in the aging brain. Synapse 1999, 32:58-66.
42. Heilig M, Koob GF, Ekman R, et al.: Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 1994, 17:80-85.
43. Lanfumey L, Mannoury La Cour C, Froger N, Hamon M: 5-HT-HPA interactions in two models of transgenic mice relevant to major depression. Neurochem Res 2000, 25:1199-1206.